Endothelial Damage in Major Spine Surgery, Measured by Circulating Syndecan-1: an Observat
The goal of this observational study is to learn about endothelial damage in major spine surgery, expressed as rise in circulating Syndecan-1. The main questions it aims to answer are: * What is the extent of endothelial glycocalyx shedding in major spine surgery? * Are there differences in different type of surgical p
| Condition(s) | Spinal Fusion |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | The goal of this observational study is to learn about endothelial damage in major spine surgery, expressed as rise in circulating Syndecan-1. The main questions it aims to answer are: * What is the extent of endothelial glycocalyx shedding in major spine surgery? * Are there differences in different type of surgical populations? (adolescent idiopathic scoliosis, adult degenerative spine disease, oncologic surgery) To do so, blood samples will be drawn from participants at the following timepoints: * basal * after surgery * if transfusion of Fresh Frozen Plasma: before and after transfusion * Post-Operative Day 1-2-4 |
| Who can participate | Inclusion Criteria: * Undergoing Major Spine Surgery with estimated blood loss\> 25% of total blood volume * American Society of Anesthesiology status 1-2-3 * Able to comprehend and sign informed consent. * If age \<18 years: parent or legal representative able to comprehend and sign informed consent Exclusion Criteria: * Surgery outside of laboratory opening hours * Patients undergoing spine surgery for genetic syndromes/neuromuscular scoliosis |
| Ages | 12 Years to 75 Years |
| Sex | All |
| Lead sponsor | Istituto Ortopedico Rizzoli |
| Locations | Bologna, BO, Italy |
| Start date | 2026-02-28 |
| NCT ID | NCT06119542 |
| Official listing | https://clinicaltrials.gov/study/NCT06119542 |